(Bloomberg) WuXi Biologics Cayman Inc. shares slumped for the second day as investors worried over a ramp-up in geopolitical tensions following a US draft bill targeting Chinese biotech companies.Most Read from BloombergTraders Line Up for ‘Once-in-a-Generation’ Emerging Markets BetSingapore’s $200,000 Toyotas Fuel Angst Over Wealth GapHouthi Hit on Russian Fuel Has Traders Recalculating RisksThree US Troops Killed in Attack Tied to Iran-Backed GroupsTrump’s Cash Stockpile at Risk From $450 M
(Bloomberg) WuXi Biologics Cayman Inc. shares slumped for the second day as investors worried over a ramp-up in geopolitical tensions following a US draft bill targeting Chinese biotech companies.Most Read from BloombergTraders Line Up for ‘Once-in-a-Generation’ Emerging Markets BetBlackstone Is Building a $25 Billion Empire of Power-Hungry Data CentersTrump Cash Stockpile at Risk From $450 Million Dual VerdictsMusk Says First Human Patient Has Received Brain ImplantAmazon Drops iRobot Deal;
(Bloomberg) WuXi Biologics Cayman Inc. shares slumped for the second day as investors worried over a ramp-up in geopolitical tensions following a US draft bill targeting Chinese biotech companies.Most Read from BloombergTrump Risks Losing More Than Half of Swing-State Voters If Found GuiltyMusk’s $55 Billion Pay Package Voided, Threatening World’s Biggest FortuneS&P 500 Has Its Worst Fed-Decision Day Since March: Markets WrapByron Allen’s Latest Takeover Bid: Paramount for $14 BillionNY Commu
(Bloomberg) WuXi AppTec Co. tumbled by an intraday record in Hong Kong, with traders attributing the decline to proposed US legislation that would ban the Chinese medical technology company and its units from government contracts. Most Read from BloombergPutin Sends US Signal on Ukraine Talks, Seeing War AdvantageUS Extends Lead Over China in Race for World’s Biggest EconomyTesla Sinks After Warning About ‘Notably Lower’ Growth RateJPMorgan Shuffles Top Managers as Jamie Dimon Prepares Succes